scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript

Steve Parsons: No, I think that’s a good insight. We have changed people’s minds on where they think they would use as they’ve broadened it. I think everybody comes into the FUROSCIX experience with, okay, I know exactly where I think I’m going to use it. I can think of a few patients. And then after spending an hour with us or two hours with us and nurses weighing in, saying things that doctors don’t necessarily hear every day, medical assistance, the advanced practice providers, we have broadened their consideration pool for who FUROSCIX can help. And so the change in behavior remains to be seen, but the change of mind is definitely taking place. And it’s getting broader. So that’s been a good experience.

Douglas Tsao: And how can you — so it’s going from what to what, most commonly?

Steve Parsons: Some doctors think this is going to be great to use after someone has been discharged in the hospital to prevent a readmission. Some doctors think the best way to avoid a readmission is to never have an admission in the first place. And so they’re catching them on the front end. Some doctors are asking us about could they finish the job a little earlier at home once they’re stabilized in the hospital? So I can’t say. Everybody has the same opinion, Doug. It’s just when they hear our full story, I think we opened their mind to all three of those potential use cases.

Douglas Tsao: Okay. Great. Thank you so much.

Steve Parsons: Thanks Doug.

Operator: Thank you. Our next question is from Naz Rahman with Maxim Group. Please proceed with your question.

Nazibur Rahman: Hi, everyone. Congrats on the recent launch. And thanks for taking our question. Just on your target hospitals and target ACPs, could you give some color on what percentage of them you’ve already reached out to? And it obviously sounds like the in-service — in-service points are key. But could you also talk a little about what the response rate has been to for your digital promotion efforts?

John Tucker: Naz, it’s John. Let me turn that over to Steve. So Steve, do you want to?

SteveParsons: So the way we target is it’s hospital-based and then it’s all the doctors around that hospital, what we call heart failure community. So we have decile 10 hospitals. We have decile 9 hospitals. We have decile 8, all the way down. We’re focused on the decile 7 through 10. On the decile 10, I think we hit 90% of them so far, with calling on doctors who are in and around the community. And decile 10 hospital has the most heart failure admissions and discharges in the United States relative to their peers. I think at decile 9s were like high 80% reach. And again, we’re not selling into the hospital. It’s where we go fishing. It’s where all the patients are. And so we talk to all the specialists in and around there.

So we’ve — gets us probably high 70s. I mean we’re — our strategy has been to focus there first. and try to hit all the doctors associated, affiliated with those hospitals where we know they’re taking care of heart failure patients with fluid overload. So that’s been the focus so far. I can’t tell you exactly what the reach to every individual target physician is so far. But I can tell you the focus on those deciles.